FucT-VIII Antibodies

Santa Cruz Biotechnology offers a broad range of FucT-VIII monoclonal antibodies for research focused on understanding fucosyltransferase VIII. FucT-VIII Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FucT-VIII is a key enzyme involved in the fucosylation of glycoproteins and glycolipids, playing a significant role in cell adhesion, signaling, and immune response. The function of FucT-VIII is particularly important in cancer biology, as altered fucosylation patterns can influence tumor progression and metastasis. Understanding FucT-VIII mechanisms can provide insights into potential therapeutic targets for various diseases. Researchers worldwide utilize FucT-VIII monoclonal antibodies to advance their studies in glycobiology and cancer research. The specificity and reliability of FucT-VIII monoclonal antibodies enable precise detection and characterization of fucosylation events in cellular processes. Detailed analysis of FucT-VIII expression and activity patterns helps reveal new pathways in disease development and potential treatment strategies. Santa Cruz Biotechnology monoclonal antibodies for FucT-VIII continue to support breakthrough discoveries in glycobiology research and therapeutic development.